2point2 Capital - Investor Update Q1 FY25
2point2 Capital - Investor Update Q1 FY25
2point2 Capital - Investor Update Q1 FY25
Dear Investors,
This is the thirty-second quarterly letter to our Investors. Our letters to you will provide an update on
our investment performance and present our views on relevant topics.
PERFORMANCE
2Point2 Long Term Value Fund
The 2Point2 Long Term Value Fund (launched in July 2016) is our only strategy under the PMS license
granted to us by SEBI. This strategy focuses on generating long term returns by holding a concentrated
portfolio of investments (15-18 stocks).
Returns Summary
Out-
2Point2 BSE 500 TRI#
performance
FY17* 26.8% 12.2% +14.6%
FY18 16.6% 13.2% +3.4%
FY19 14.4% 9.7% +4.7%
FY20 -24.6% -26.5% +1.9%
FY21 73.9% 78.6% -4.7%
FY22 17.8% 22.3% -4.5%
FY23 10.0% -0.9% +10.9%
FY24 45.2% 40.2% +5.0%
YTD FY25 10.7% 11.7% -1.0%
CAGR Return 21.2% 16.9% 4.3%
Cumulative Return* 362.3% 247.1% 115.2%
*FY17 returns are for an 8-month period. Cumulative returns are from 20 th July 2016 to 30th June 2024. As
mandated by SEBI, returns are calculated on a time-weighted basis (TWRR) on aggregate portfolio. Returns are
net of expenses and fees. Performance related information provided here is not verified by SEBI.
#
TRI is Total Return Index – includes returns from dividends received
Note: Returns of individual clients will differ from the above numbers based on the timing of their
investments. The above returns are on the consolidated pool of capital.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
2Point2 Capital Advisors LLP
www.2point2capital.com | 72080 02358 | [email protected]
914, The Summit Business Bay, Andheri-Kurla Road, Andheri East, Mumbai - 400093
COMMENTARY
Our portfolio returned 10.7% in Q1 FY25. The BSE 500, Nifty 50 and Nifty Midcap 100 index generated
returns of 11.7%, 8.1% and 16.1% in this period. As of 30th June, we had a 89.9% equity exposure (ex
of REITs) in the PMS on a consolidated basis (new portfolios would have lower exposure), with the
rest lying in interest earning assets. Our portfolio companies reported a median YoY profit growth of
19% in Q4 FY24.
For eg. You meet Steve, a person who is quiet, loves reading, and is very organized. When asked if he
is more likely to be a librarian or a salesperson, many might say librarian. This judgment ignores the
base rate that there are far more salespeople than librarians in this world, making it statistically more
likely that Steve is a salesperson, despite the personality description.
Source: versusthemachines.com
Daniel Kahneman in his book Thinking, Fast and Slow described two modes of thinking – System 1
and System 2. System 1 is fast, automatic and does not require any effort. It allows us to take quick
decisions based on intuition and experience. System 2 is slow, deliberate and requires considerable
mental effort. It helps us solve complex problems which require lot of thought.
Base rate neglect is driven by us using System 1 thinking over System 2 in most cases. We jump to
conclusions based on anecdotal information (System 1) and avoid the time-consuming task of
incorporating the base rate information (System 2). In many cases, the error is also compounded due
to our lack of knowledge of the prior base rates.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
2Point2 Capital Advisors LLP
www.2point2capital.com | 72080 02358 | [email protected]
914, The Summit Business Bay, Andheri-Kurla Road, Andheri East, Mumbai - 400093
In most instances, base rate neglect leads to errors without any serious consequences. But in some
cases, base rate neglect is a matter of life and death. We saw this play out during the Covid-19
pandemic. In 2021 and 2022, a number of media articles across the world reported on the fact that
most Covid-19 hospitalizations and deaths comprised those who had received Covid-19 vaccines. The
data seemed to suggest that the vaccines were ineffective or even worsened the Covid-19 impact. This
information was widely shared on social media and fuelled vaccine scepticism.
This was an erroneous conclusion driven by an ignorance of base rates. As a large % of the population
had already received the vaccine, it was normal for vaccinated people to comprise a large % of
hospitalizations despite the vaccine being quite effective.
• For eg. In a town of 100k people, 90k are vaccinated and 10k are unvaccinated. 1000 people
have been hospitalized in this town due to Covid of whom 600 were vaccinated and 400 were
unvaccinated.
• Without considering the vaccination rate in the population, the higher number of vaccinated
patients in the hospitals paints a scary picture. One might conclude that vaccinated people
are more likely to contract COVID than unvaccinated people. However, when you consider the
vaccination rate in the population, it means that 4% (400/10000) of unvaccinated people were
hospitalized compared to 0.67% (600/90000) of vaccinated people. This means that the
unvaccinated were 6x more likely to be hospitalized than the vaccinated or that vaccines
reduced the likelihood of hospitalization by 83%.
Base rate neglect led some people to avoid vaccination, fearing the negative effects despite the
vaccines being incredibly effective at reducing hospitalizations and deaths.
Source: https://x.com/MarcRummy/status/1464178903224889345
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
2Point2 Capital Advisors LLP
www.2point2capital.com | 72080 02358 | [email protected]
914, The Summit Business Bay, Andheri-Kurla Road, Andheri East, Mumbai - 400093
Absurd Valuations
The Indian stock market has been on a remarkable upward trajectory over the last few years.
The rally has been quite broad-based with mid-caps and small-caps doing better than large-caps.
While many companies have seen healthy earnings growth, a large part of the rise in stock prices has
been driven by an increase in valuation multiples.
Small and mid-cap valuations, in particular, have reached absurd levels never before seen in India’s
capital market history (not even in 2018 or 2008). Of the top 1000 companies by market cap, 217
stocks trade at valuations above 75x TTM P/E and 392 above 50x TTM P/E.
Some investors justify the rich valuations on the basis of the high expected future earnings growth of
these companies. Their expectations are driven by narratives of fast economic growth, multi-decadal
industry tailwinds and favourable government policies. We believe this optimism suffers from base
rate neglect.
The data of historical earnings growth suggests that very few companies are able to deliver high
growth rates over a long period of time. The number of companies that are able to grow rapidly from
an already high base of profits is even smaller. In other words, the base rate of companies growing at
a rapid pace from an already high base over a long period of time is very low. However, the valuations
in the Indian market do not seem to account for these base rates.
As of now, there are 14 companies that generate > 500 crs annual profit and trade at valuations >100x
P/E3. At a starting P/E of 100x and assuming an exit multiple of 30x P/E, these companies would need
to grow earnings at a CAGR of 26% to deliver 12% annual returns over the next decade. Given this
expectation, it is useful to look at the base rate of such high growth for an already large business.
Only 3 businesses that had a profit > 250 crs4 in 2014 were able to deliver an EPS CAGR > 26% (Bajaj
Finance, Eicher Motors, HPCL) over the next 10 years. This shows the low base rate of large companies
delivering sustained high growth. If an investor in 2014 had perfect foresight regarding future earnings
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
2Point2 Capital Advisors LLP
www.2point2capital.com | 72080 02358 | [email protected]
914, The Summit Business Bay, Andheri-Kurla Road, Andheri East, Mumbai - 400093
growth but invested in these 3 companies at > 100x P/E, they would not have made even a 12% annual
portfolio return. Those investing at these valuations today are taking the risk of low base rate of high
earnings growth while making sub-par returns even if the high growth rate is achieved.
As can be seen from the table below, the base rate challenge is not just limited to ultra-high valuations
but even at relatively lower but still rich valuations.
Minimum Current Number Reqd EPS CAGR for Cos that achieved Reqd
Starting P/E of Companies 12% annual return EPS CAGR over 2014-2024
100x 14 26.3% 3
75x 31 22.7% 5
50x 71 17.9% 15
Note: Current number of companies only considers those that generated >500 crs of profit in 2024 and excludes
those that had an ROE of less than 12%. For base rate calculations, only those companies that generated >250
crs of profit in 2014 are considered. Exit P/E assumption of 30x. Source: Screener.in
Base rate neglect, where individuals ignore historical base rates in favour of specific, anecdotal
evidence, can lead investors to pay excessively high valuations for companies with perceived potential
for rapid growth. When investors focus on the exciting prospects of a company, they may overlook
the broader statistical realities that most companies fail to achieve sustained high growth. This
overemphasis on specific success stories can skew their perception, making them believe that
exceptional growth is more common than it statistically is.
Just as we should avoid judging a shy Steve to be a librarian instead of a salesperson, we should avoid
paying an excessive price for a business with a strong narrative without considering the base rates.
Source: https://xkcd.com/2476/
If you have any queries (about your portfolio, 2Point2 Capital or investing in general), do reach out
to us at the below coordinates. We would love to talk.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
2Point2 Capital Advisors LLP
www.2point2capital.com | 72080 02358 | [email protected]
914, The Summit Business Bay, Andheri-Kurla Road, Andheri East, Mumbai - 400093